Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $26.02 in the prior trading day, Capricor Therapeutics Inc (NASDAQ: CAPR) closed at $26.55, up 2.04%. In other words, the price has increased by $2.04 from its previous closing price. On the day, 1.24 million shares were traded. CAPR stock price reached its highest trading level at $27.175 during the session, while it also had its lowest trading level at $25.84.
Ratios:
Our goal is to gain a better understanding of CAPR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.59 and its Current Ratio is at 3.59. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In the most recent recommendation for this company, Alliance Global Partners on June 30, 2025, initiated with a Buy rating and assigned the stock a target price of $20.
On June 26, 2025, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $21.
On May 20, 2025, Roth Capital started tracking the stock assigning a Buy rating and target price of $31.Roth Capital initiated its Buy rating on May 20, 2025, with a $31 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAPR now has a Market Capitalization of 1444300928 and an Enterprise Value of 1129802368. For the stock, the TTM Price-to-Sale (P/S) ratio is 129.77 while its Price-to-Book (P/B) ratio in mrq is 14.47. Its current Enterprise Value per Revenue stands at 101.505 whereas that against EBITDA is -13.304.
Stock Price History:
The Beta on a monthly basis for CAPR is 0.19, which has changed by 0.97121215 over the last 52 weeks, in comparison to a change of 0.12838376 over the same period for the S&P500. Over the past 52 weeks, CAPR has reached a high of $40.37, while it has fallen to a 52-week low of $4.30. The 50-Day Moving Average of the stock is 165.05%, while the 200-Day Moving Average is calculated to be 176.96%.
Shares Statistics:
The stock has traded on average 2.82M shares per day over the past 3-months and 9464790 shares per day over the last 10 days, according to various share statistics. A total of 54.40M shares are outstanding, with a floating share count of 47.82M. Insiders hold about 12.10% of the company’s shares, while institutions hold 31.82% stake in the company. Shares short for CAPR as of 1764288000 were 16419579 with a Short Ratio of 5.83, compared to 1761868800 on 13254083. Therefore, it implies a Short% of Shares Outstanding of 16419579 and a Short% of Float of 40.86.
Earnings Estimates
. The current rating of Capricor Therapeutics Inc (CAPR) reflects the combined expertise of 8.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.51, with high estimates of -$0.44 and low estimates of -$0.57.
Analysts are recommending an EPS of between -$1.9 and -$2.23 for the fiscal current year, implying an average EPS of -$2.13. EPS for the following year is $0.41, with 8.0 analysts recommending between $3.09 and -$2.36.
